P PRIMESTOCKFINDER.COM

BLG Shares BluGlass Limited

ACCUMULATE ASX · ASX
$0.20 -2.50% Prices as of close 2026-10-26

Vertically integrated GaN manufacturer targeting defence, quantum, and photonics markets with meaningful commercialisation upside.

Future value: $0.32 (+64.10%) · 6-12 months

  • ▸Growing strategic applications, but execution and commercialisation remain key risks.
  • ▾Below 50-day MA (-17.91%)
  • ▾Near 52-week low (5.3% of range)
  • ▸~64% upside to price target

Trend: BLG is trading below the 50-day average (-16.67%), RSI 52 — neutral momentum, with a 3-month return of -39.39%.

Valuation & quality: BluGlass Limited trades on price-to-book 2.63; fundamentals show net margin -255.9%, return on equity -79.9%, revenue growth -54.6% year on year.

Our screen: ACCUMULATE (score 1) — Vertically integrated GaN manufacturer targeting defence, quantum, and photonics markets with meaningful commercialisation upside.

Computed from end-of-day data; not personal advice.

0.47 0.18 FebMarAprMayJunJulAugSepOct
Daily close, 2026-02-08 → 2026-10-25 (AUD). Range 0.18 – 0.47.
Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
+25.00%-8.00%+26.10%+13.80%+6.10%-8.60%-31.20%-9.10%
Market cap
$38.5M
EPS (ttm)
$-0.07
Price / book
2.63
Beta
-0.05
Net margin
-255.9%
ROE
-79.9%
Revenue growth
-54.6%
Revenue (ttm)
$4.1M
Free cash flow
$-5,624,569
Debt / equity
56%
52-wk range
$0.18 – $0.55
Volume
132,977
Avg volume (3m)
244,222
RSI (14)
52.2
vs 50-day MA
-16.67%
1-mo return
-11.11%
3-mo return
-39.39%
Volume z-score
0.31

BluGlass Limited, together with its subsidiaries, provides semiconductor manufacturing technology and devices for biotech, defense, quantum, consumer electronic sectors in Australia and the United States.

Sector: Technology · Industry: Semiconductor Equipment & Materials · Australia · Website

Browse: all ASX stocks · Semiconductors picks · today's movers

General information only (Australia). This is general information, not financial product advice. It doesn't consider your objectives, financial situation or needs — consider its appropriateness and seek licensed advice before acting. Not a recommendation to buy or sell any financial product.

Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.